Just what women need as their access to abortion, birth control and other aspects of reproductive healthcare is being severely restricted across the country a miracle diet supplement that can result in an unwanted pregnancy
For people who experience severe nausea with injectable semaglutide leading to dehydration and UTI risk, oral formulations might offer a way to continue GLP-1 therapy with a more tolerable side effect profile
Some insurance companies and employers have been hesitant to cover the treatments due to their high cost
The analysts said GLP-1 sales could reach $102 billion by 2030, of which obesity is projected to contribute $41 billion. Two leaders in this field are expected to take roughly 44% and 52% share, respectively, of the global GLP-1 market in 2030. With high financial gain predicted, supply issues have been raised concerning how companies will meet the growing demand
Available as both an injectable and an oral pill, semaglutide mimics the GLP-1 hormone, effectively reducing appetite and facilitating substantial weight loss